Afuco™ Anti-Human TSG101 ADCC Therapeutic Antibody (FGI-101-1A6), ADCC Enhanced

Anti-TSG101 ADCC Enhanced Antibody (FGI-101-1A6) is an ADCC enhanced antibody produced by our Afuco™ platform. FGI-101-1A6 is a broad spectrum anti-TSG101 monoclonal antibody demonstrating broad in vitro anti-viral activity against several strains of Influenza and HIV.
Supplier Creative Biolabs
Product # AFC-624CL
Pricing Inquiry
Host Human
Target TSG101
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4°C or -20°C, avoid repeated freezing and thawing.
Feedback